drugset / Trial / NCT03781765
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Phase 4
Recruiting
44 enrolled
Icahn School of Medicine at Mount Sinai
National Institute on Drug Abuse (NIDA) · collab
RandomizedSingle-groupOpen-labelBasic science
Summary
The study team will examine the effects of FDA approved stimulant and non-stimulant medications for ADHD, among youth with ADHD and with and without Oppositional Defiant Disorder (ODD) or Conduct Disorder (CD), on reward systems of the brain using fMRI.
Timeline
- Start
- 2019-06-04
- Primary completion
- 2025-09-25
- Completion
- 2025-09-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Atomoxetine | Other / unclassified | 1 mg/kg | — |
| Comparator | Methylphenidate | Small molecule | 1 mg/kg | — |